Events

Videos

Podcasts

Articles

Gastrointestinal Cancer

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Rachna Shroff, MD, MS, FASCO, highlights the prominence of the EMERALD-1 study for patients with HCC.

EMERALD-1 Study: Significance as Presented at ASCO GI 2024

Michael Morse, MD, establishes his criteria for implementing TACE versus systemic therapy in HCC treatment.

Determining Transarterial Chemoembolization (TACE) Candidacy for Patients with HCC

Mechanism of action for liver-directed therapies in HCC are illustrated by Anne Covey, MD, an interventional radiologist.

Utilizing Interventional Radiology and Liver-directed Therapies

Anthony El-Khoueiry, MD, opens the discussion by defining the current prevalence of hepatocellular carcinoma (HCC).

Hepatocellular Carcinoma (HCC) Disease State Overview

Riccardo Lencioni, MD, FSIR, EB, discusses the EMERALD-1 trial of TACE/durvalumab/bevacizumab in patients with unresectable hepatocellular carcinoma.

Hepatocellular Carcinoma | Specialty

EMERALD-1 Study: Significance as Presented at ASCO GI 2024

Determining Transarterial Chemoembolization (TACE) Candidacy for Patients with HCC

Utilizing Interventional Radiology and Liver-directed Therapies

Hepatocellular Carcinoma (HCC) Disease State Overview

Dr Lencioni on the Results of the EMERALD-1 Trial in Unresectable HCC